Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Squamous Cell

Explore clinical trials studying Carcinoma, Squamous Cell. Study availability and eligibility vary by location and protocol.

1,689 public trials 444 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Squamous Cell trial results

Terminated

A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer

NCT04844073

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +30 more
Locations
  • UC San Diego Moores Cancer Center San Diego, California, United States
  • University of California San Francisco San Francisco, California, United States
  • University of Colorado - Anschutz Medical Campus - PPDS Aurora, Colorado, United States
  • Yale University New Haven, Connecticut, United States
View all 27 locations
View Trial Details
Terminated

Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

NCT06790966

Conditions
Carcinoma, Carcinoma, Squamous Cell, HPV Positive Oropharyngeal Squamous Cell Carcinoma, +11 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Marin Cancer Care Greenbrae, California, United States
  • University of California, Orange Orange, California, United States
  • Yale University New Haven, Connecticut, United States
View all 28 locations
View Trial Details
Terminated

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014).

NCT04949256

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +14 more
Locations
  • City of Hope ( Site 0102) Duarte, California, United States
  • MedStar Washington Hospital Center ( Site 0186) Washington D.C., District of Columbia, United States
  • James Graham Brown Cancer Center ( Site 0117) Louisville, Kentucky, United States
  • Norton Cancer Institute ( Site 0116) Louisville, Kentucky, United States
View all 198 locations
View Trial Details
Terminated

Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications

NCT05827614

Conditions
Anogenital Cancer, Breast Diseases, Breast Neoplasms, +38 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • Sarcoma Oncology Santa Monica, California, United States
  • HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists Lake Mary, Florida, United States
View all 16 locations
View Trial Details
Suspended

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

NCT01810913

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +14 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • The Kirklin Clinic at Acton Road Birmingham, Alabama, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
View all 342 locations
View Trial Details

Related conditions